바이오서저리 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global biosurgery market size is expected to reach USD 31.92 Billion in 2034 from USD 17.99 Billion in 2025, growing at a CAGR of 6.58% during 2026-2034.This market is experiencing strong growth driven by the increasing number of surgical procedures and the rising demand for advanced hemostatic and tissue-sealing solutions. Biosurgery products, including surgical sealants, hemostats, and adhesion barriers, are widely used to control bleeding, promote healing, and reduce complications during and after surgery. The growing prevalence of chronic diseases requiring surgical intervention, along with the expansion of minimally invasive procedures, is significantly contributing to market expansion across healthcare systems worldwide.

Key drivers include advancements in biomaterials, increasing healthcare expenditure, and the rising adoption of innovative surgical techniques. Surgeons are increasingly relying on biosurgery products to enhance precision, reduce operation time, and improve patient outcomes. The expansion of ambulatory surgical centers and improved access to healthcare services in emerging markets are also supporting demand. Additionally, ongoing research and development efforts are leading to the introduction of more effective and biocompatible products.

Future prospects for this market remain promising, with continued innovation in regenerative medicine and tissue engineering. The development of next-generation biosurgical solutions with enhanced efficacy and safety profiles is expected to drive growth. Emerging markets are likely to offer significant opportunities due to improving healthcare infrastructure. As surgical procedures become more advanced and patient-centric, the biosurgery market is poised for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Surgical Sealants
• Hemostatic Agents
• Adhesion Barriers
• Soft Tissue Attachments
• Bone Graft Attachments
• Others

By Application

• General Surgery
• Orthopedic Surgery
• Cardiovascular Surgery
• Neurological Surgery
• Others

COMPANIES PROFILED

• Sanofi, Baxter, Integra Lifesciences, Medtronic, B. Braun SE, Pfizer Inc, Stryker, Johnson & Johnson Services Inc, BD, Artivion Inc (CryoLife Inc.)

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOSURGERY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Surgical Sealants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hemostatic Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Adhesion Barriers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Soft Tissue Attachments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Bone Graft Attachments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOSURGERY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. General Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Orthopedic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cardiovascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Neurological Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOSURGERY MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Spain
  • 6.3.8 Russia
  • 6.3.9 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Application
  • 6.4.3 China
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 India
  • 6.4.7 Australia
  • 6.4.8 South East Asia
  • 6.4.9 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BIOSURGERY INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Sanofi
  • 8.2.2 Baxter
  • 8.2.3 Integra Lifesciences
  • 8.2.4 Medtronic
  • 8.2.5 B. Braun SE
  • 8.2.6 Pfizer Inc
  • 8.2.7 Stryker
  • 8.2.8 Johnson & Johnson Services Inc
  • 8.2.9 BD
  • 8.2.10 Artivion Inc (CryoLife Inc.)